document type sequence filename xenetic_ description second amendment research development license agreement text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style font time roman time serif margin portion this exhibit indicated mark ldquo rdquo have been redacted pursuant confidential treatment request style margin margin bottom font time roman text align left style margin margin bottom font size font family time roman align center second amendment exclusive style margin margin bottom font size font family time roman align center research development license agreement style margin margin bottom text indent font size font family time roman this second amendment exclusive research development license agreement this amendment made entered into this style font size vertical align among lipoxen technology limited company registered england wale with company number having registered office london bioscience innovation centre royal college london england lipoxen baxter healthcare bhsa corporation organized existing under switzerland baxter healthcare corporation having principal place business baxter parkway deerfield illinois bhsa collectively referred baxter amend term that certain exclusive research development license agreement between party dated august nbsp which amended pursuant that certain amendment between party dated about december nbsp together agreement lipoxen baxter referred herein individually party collectively party style margin margin bottom font size font family time roman align center background style margin margin bottom text indent font size font family time roman whereas pursuant section nbsp schedule agreement baxter obligated make milestone payment amount upon nbsp formal selection lead candidate multiple product developed simultaneously lead candidate research committee baxter nbsp entry into clinical trial anywhere world first milestone event style margin margin bottom text indent font size font family time roman whereas lipoxen proposed baxter that lipoxen upon occurrence either both such milestone event baxter offering lipoxen style margin margin bottom text indent font size font family time roman whereas baxter date this amendment entered into that certain subscription agreement pursuant which baxter made investment ordinary share lipoxen amount million dollar quot equity investment quot style margin margin bottom text indent font time roman whereas result equity investment party wish amend agreement clarify that baxter further obligation upon occurrence either first milestone event style margin margin bottom text indent font size font family time roman therefore consideration foregoing such other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style margin margin bottom font size font family time roman align center agreement style margin margin bottom text indent font size font family time roman incorporation agreement capitalized term which defined herein shall have same meaning forth agreement agreement extent inconsistent with this amendment incorporated herein this reference though same forth entirety extent term provision agreement inconsistent with amendment forth paragraph below such term provision shall deemed superseded hereby except specifically forth herein agreement shall remain full force effect provision shall binding party hereto style margin margin bottom text indent font size font family time roman amendment agreement agreement hereby amended follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amendment schedule schedule agreement hereby deleted entirety shall replaced with schedule attached this amendment exhibit table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign avoidance doubt party acknowledge that baxter exercised option forth section agreement around nbsp december table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amendment section nbsp section nbsp hereby deleted entirety shall replaced with following table style margin margin bottom margin left font size font family time roman there shall multiple milestone payment multiple product multiple indication except that baxter shall required make milestone payment event style margin margin bottom margin left text indent font size font family time roman baxter entered into clinical trial development potential product specific label indication style margin margin bottom margin left text indent font size font family time roman baxter terminated such clinical trial elect purse development this different potential product with different label indication within field style margin margin bottom margin left text indent font size font family time roman termination development potential product clinical trial failure meet satisfactory clinical endpoint clinical failure style margin margin bottom margin left text indent font size font family time roman such event milestone payment shall lead candidate developed label indication anywhere world relation more different potential product with different label indication within field label indication same disease area shall considered same label indication example indication control spontaneous bleeding episode cover surgical intervention hemophilia indication prevention control hemorrhagic episode hemophilia shall considered same label indication style margin margin bottom margin left text indent font size font family time roman clarity event baxter develops multiple potential product with same label indication whether simultaneously sequentially whether preclinical clinical trial launch multiple commercial product with same label indication pursuant this section nbsp event baxter launch multiple potential product with different label indication whether simultaneously sequentially whether preclinical clinical trial launch multiple commercial product with different label indication pursuant this section nbsp event baxter cancel development potential product clinical failure develops another potential product whether same different label indication pursuant this section nbsp style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman example baxter terminates development potential product with targeted indication prior initiating clinical trial elect develop different potential product with targeted indication then pursuant this section nbsp shall style margin margin bottom margin left text indent font time roman example baxter terminates development potential product with targeted indication after initiating clinical trial there been clinical failure elect develop different potential product with targeted indication then addition other milestone payment milestone payment pursuant this section payable lipoxen upon selection lead candidate upon entry different potential product into clinical trial anywhere world style margin margin bottom margin left text indent font time roman style margin margin bottom text indent font size font family time roman effectuation amendment agreement contemplated this amendment shall deemed effective date first written above upon full execution this amendment without further action required party hereto condition that equity investment completed quot condition quot condition satisfied june this amendment shall expire style margin margin bottom text indent font size font family time roman counterpart this amendment executed more counterpart each which shall deemed original which together shall constitute same instrument more counterpart this amendment delivered facsimile with intention that delivery such mean shall have same effect delivery original counterpart thereof style margin margin bottom text indent font size font family time roman witness whereof party hereto have duly executed this amendment date first above written style margin margin bottom font size font family time roman align center signature page follows style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan baxter healthcare corp valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan lipoxen technology limited height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign style border bottom solid style margin margin bottom font size font family time roman amundson valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style border bottom solid style margin margin bottom font size font family time roman scott maguire style font family time roman font size valign colspan style margin left text indent font size font family time roman name amundson valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font valign bottom colspan name scott maguire style font family time roman font size valign colspan style margin left text indent font size font family time roman title president bioscience valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font valign bottom colspan title height colspan height colspan height colspan height colspan style font family time roman font size valign colspan baxter healthcare valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign bottom height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign style border bottom solid style margin margin bottom font size font family time roman lgnacio martinez lecea valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font size nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman name lgnacio martinez lecea valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font colspan valign bottom style font family time roman font size valign colspan style margin left text indent font size font family time roman title corporate counsel valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font colspan valign bottom height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign style border bottom solid style margin margin bottom font size font family time roman sarah byrne quinn valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign style font size nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman name sarah byrne quinn valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font colspan valign bottom style font family time roman font size valign colspan style margin left text indent font size font family time roman title valign bottom font style font size nbsp font valign bottom valign bottom font style font size nbsp font colspan valign bottom table style margin margin bottom font size font family time roman align center signature page second amendment style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center milestone event payment style margin margin bottom font size font family time roman forth section then pursuant section following milestone payment upon occurrence following milestone event with respect potential product commercial product case unless fully paid under schedule style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width height height colspan style font family time roman font size valign style margin left text indent font size font family time roman milestone event valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman acceptance european equivalent valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman completion phase clinical trial anywhere world valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman completion phase clinical trial anywhere world valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman regulatory approval valign bottom font style font size nbsp nbsp font valign bottom valign bottom valign bottom height height colspan style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp europe valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman sale milestone addition royalty payable valign bottom font style font size nbsp nbsp font valign bottom valign bottom valign bottom height height colspan style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp first year world wide valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp first year world wide valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp height height colspan style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp first year world wide valign bottom font style font size nbsp nbsp font valign bottom nbsp valign bottom align right nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nowrap valign bottom nbsp nbsp table body html text document